Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
165.12
+0.65 (+0.40%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,924,814
Open
164.89
Bid (Size)
164.70 (1)
Ask (Size)
165.12 (10)
Prev. Close
164.47
Today's Range
163.93 - 165.29
52wk Range
143.13 - 168.85
Shares Outstanding
2,628,679,824
Dividend Yield
2.88%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
Today 9:57 EDT
These companies' longtime shareholders have generally been rewarded.
Via
The Motley Fool
Three Safe Dividend Kings to Weather Any Storm
October 18, 2024
Income investors should focus on stocks with solid yields, sustainable payouts, and strong business models. One way to achieve this is by investing in safe dividend kings.
Via
Talk Markets
Performance
YTD
+3.22%
+3.22%
1 Month
-0.62%
-0.62%
3 Month
+6.74%
+6.74%
6 Month
+11.64%
+11.64%
1 Year
+8.40%
+8.40%
More News
Read More
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug
October 18, 2024
Via
Benzinga
Johnson & Johnson Unusual Options Activity
October 18, 2024
Via
Benzinga
Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review
October 18, 2024
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Johnson & Johnson’s Medtech Segment Shines With Impressive Q3 Growth
October 15, 2024
Via
Talk Markets
Why NYSE:JNJ is a Top Pick for Dividend Investors.
October 15, 2024
Via
Chartmill
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
October 18, 2024
Via
The Motley Fool
This Magnificent Dividend Stock Is as Healthy as It Gets
October 17, 2024
Via
The Motley Fool
Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say
October 16, 2024
Via
Benzinga
Johnson & Johnson Stock: Setting the Stage for 2025 Highs
October 16, 2024
Via
MarketBeat
Exposures
COVID-19
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
October 16, 2024
Via
The Motley Fool
Are JNJ’s Mergers And Acquisitions Weighing Down Company’s Performance?
October 15, 2024
Via
Talk Markets
Cancer Drugs Propel J&J Beyond Wall Street Estimates
October 15, 2024
Via
Benzinga
Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript
October 15, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
October 15, 2024
Via
Benzinga
Chipmaker Stocks Sink On ASML Earnings Leak, Oil Eyes Worst 1-Day Drop This Year, Small Caps Rally: What's Driving Markets Tuesday?
October 15, 2024
Via
Benzinga
Google Goes Nuclear For AI Power, Israeli Restraint Impacts Stocks, Gold, And Oil
October 15, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Johnson & Johnson's Q3 Earnings: Revenue And EPS Beat On Strong Cancer Drug Sales, Revises Annual Outlook To Reflect V-Wave Acquisition
October 15, 2024
Via
Benzinga
Johnson & Johnson Earnings Top; Dow Giant Works Toward Buy Point
October 15, 2024
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Wall Street On Edge As Nasdaq Nears Record High, Oil Prices Plummet: Strategist Says There's Opportunity If Resilience Continues
October 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024
October 15, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Reports Q3 2024 Results
October 15, 2024
From
Johnson & Johnson
Via
Business Wire
Jim Cramer Says Earnings Season Will Fuel Market's Record Run, But Warns Of This 'Horrendous' Headwind That Could Apply Brakes To Rally
October 15, 2024
Via
Benzinga
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce
October 14, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.